Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.
about
Long non-coding RNAs in normal and malignant hematopoiesisTowards Stratified Medicine in Plasma Cell MyelomaIdentification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors.LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomeAssociation of lnc-LAMC2-1:1 rs2147578 and CASC8 rs10505477 Polymorphisms with Risk of Childhood Acute Lymphoblastic LeukemiaIn Silico Characterization of miRNA and Long Non-Coding RNA Interplay in Multiple Myeloma.Long non-coding RNAs in B-cell malignancies: a comprehensive overview.Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.Deregulated expression of long non-coding RNA UCA1 in multiple myeloma.Long Non-Coding RNAs in Multiple Myeloma.LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma.Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.Long non-coding RNA MALAT1 is an inducible stress response gene associated with extramedullary spread and poor prognosis of multiple myeloma.The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma.Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma.Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.Recently Evolved Tumor Suppressor Transcript TP73-AS1 Functions as Sponge of Human-Specific miR-941.A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma.MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy
P2860
Q28070169-DCD63650-3E88-486E-A8F4-A23EEBA8A331Q28074994-E69895E6-E448-4297-A323-5A72538FECD1Q37373624-C13A1B2F-4DDD-4AF0-B450-25E0C564049EQ37523103-C995DBB4-5076-47EB-9AB0-E567DA8EB415Q38822886-7B941C71-B88C-4EEB-92C4-7B8D5EA61146Q39054186-0BA25ACA-AA4B-49C9-8BEE-1216CB7D1FC4Q40046832-F9508400-DFE5-481C-93BB-B86EC8F78DEDQ41694305-D4381C6B-3A06-4A0A-BEBE-B09B0667E78FQ47149175-BEA56F59-2018-4602-AEF1-4AD63F2CE0E3Q48097529-28C95E4E-3AAB-4602-B5BA-F0E4FDCBE937Q48124218-5C2E3AEE-FE30-4C29-ABF0-EEDA4DF953A6Q48125035-FDF64EB8-7E3C-4B3F-B848-3035C88CC764Q48196873-D36F5677-9326-4046-BBBA-70D460749D99Q48300802-35D47C33-0DFA-4B77-9422-587830C5E7CAQ49872152-477ADD9E-4EF8-48DB-81C6-FF51E13AA7F4Q52327430-11E05639-2B13-49D2-A2C8-7F85ED7DD70EQ52682394-927567DF-22C5-4966-AD46-CF787D8ED674Q55024937-85CAEB4E-E8A5-41DE-9F3B-35CA85B35F6DQ55082350-5C7492DA-FF0F-4CC1-8269-025EE4F491DAQ55245371-4AD9CC55-8228-4190-B07D-B5937762F3A5Q58725483-4DCAB969-FFE1-4800-A7F7-7CA6DA8D2DC0
P2860
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Distinct lncRNA transcriptiona ...... ve stages of multiple myeloma.
@en
type
label
Distinct lncRNA transcriptiona ...... ve stages of multiple myeloma.
@en
prefLabel
Distinct lncRNA transcriptiona ...... ve stages of multiple myeloma.
@en
P2860
P50
P356
P1433
P1476
Distinct lncRNA transcriptiona ...... ive stages of multiple myeloma
@en
P2093
Serena Galletti
P2860
P304
14814-14830
P356
10.18632/ONCOTARGET.7442
P407
P50
P577
2016-03-01T00:00:00Z